Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation

Neuron

Volumn 21, Issue 4, 1998, Pages 799-811

  Jiang, Yong hui ^a   Armstrong, Dawna ^a   Albrecht, Urs ^a   Atkins, Coleen M ^a   Noebels, Jeffrey L ^a   Eichele, Gregor ^a   Sweatt, J David ^a   Beaudet, Arthur L ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGASE; PROTEIN P53; UBIQUITIN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE MUTATION; HAPPY PUPPET SYNDROME; HIPPOCAMPUS; LEARNING DISORDER; LONG TERM POTENTIATION; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PURKINJE CELL; SEIZURE; SYNAPTIC TRANSMISSION;

EID: 0032192481     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80596-6     Document Type: Article

References (69)

1. Albrecht, U., Sutcliffe, J.S., Cattanach, B.M., Beechey, C.V., Armstrong, D., Eichele, G., and Beaudet, A.L. (1997). Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nat. Genet. 17, 75-78.
2. Barria, A., Muller, D., Derkach, V., Griffith, L.C., and Soderling, T.R. (1997). Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. Science 276, 2042-2045.
3. Bartolomei, M.S., and Tilghman, S.M. (1997). Genomic imprinting in mammals. Annu. Rev. Genet. 31, 493-525.
4. Baumeister, W., Walz, J., Zühl, F., and Seemüller, E. (1998). The proteasome: paradigm of a self-compartmentalizing protease. Cell 92, 367-380.
5. Beer-Romero, P., Glass, S., and Rolfe, M. (1997). Antisensetargeting of E6AP elevates p53 in HPV-infected cells but not in normal cells. Oncogene 14, 595-602.
6. Bergold, P.J., Beushausen, S.A., Sacktor, T.C., Cheley, S., Bayley, H., and Schwartz, J.H. (1992). A regulatory subunit of the cAMP-dependent protein kinase down-regulated in Aplysia sensory neurons during long-term sensitization. Neuron 8, 387-397.
7. Buiting, K., Saitoh, S., Gross, S., Bittrich, B., Schwartz, S., Nicholls, R.D., and Horsthemke, B. (1995). Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nat. Genet. 9, 395-400.
8. Bullard, D.C., Kunkel, E.J., Kubo, H., Hicks, M.J., Lorenzo, I., Doyle, N.A., Doerschuk, C.M., Ley, K., and Beaudet, A.L. (1996). Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice. J. Exp. Med. 183, 2329-2336.
9. Cattanach, B.M., Barr, J.A., Beechey, C.V., Martin, J., Noebels, J., and Jones, J. (1997). A candidate model for Angelman syndrome in the mouse. Mamm. Genome 8, 472-478.
10. Chain, D.G., Hegde, A.N., Yamamoto, N., Liu-Marsh, B., and Schwartz, J.H. (1995). Persistent activation of cAMP-dependent protein kinase by regulated proteolysis suggests a neuron-specific function of the ubiquitin system in Aplysia. J. Neurosci. 15, 7592-7603.
11. Chen, Z.J., Parent, L., and Maniatis, T. (1996). Site-specific phosphorylation of IkBα by a novel ubiquitination-dependent protein kinase activity. Cell 84, 853-862.
12. 2+ channel activity in area CA1 of hippocampus. Proc. Natl. Acad. Sci. USA 88, 6467-6471.
13. Ciechanover, A. and Schwartz, A.L. (1998). The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death. Proc. Natl. Acad. Sci. USA 95, 2727-2730.
14. Clark, H.B., Burright, E.N., Yunis, W.S., Larson, S., Wilcox, C., Hartman, B., Matilla, A., Zoghbi, H.Y., and Orr, H.T. (1997). Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations. J. Neurosci. 17, 7385-7395.
15. Daniels, P.R., Sanders, C.M., and Maitland, N.J. (1998). Characterization of the interactions of human papillomavirus type 16 E6 with p53 and E6-associated protein in insect and human cells. J. Gen. Virol. 79, 489-499.
16. 2+/calmodulin-dependent protein kinase II. J. Biol. Chem. 268, 7863-7867.
17. Ghirardi, M., Montarolo, P.G., and Kandel, E.R. (1995). A novel intermediate stage in the transition between short-and long-term facilitation in the sensory to motor neuron synapse of aplysia. Neuron 14, 413-420.
18. Glenn, C.C., Driscoll, D.J., Yang, T.P., and Nicholls, R.D. (1997). Genomic imprinting: potential function and mechanisms revealed by the Prader-Willi and Angelman syndromes. Mol. Hum. Reprod. 3, 321-332.
19. Harbers, K., Li, E., Grams, A., Li, E., Jaenisch, R., and Franz, T. (1996). Provirus integration into a gene encoding a ubiquitin-conjugating enzyme results in a placental defect and embryonic lethality. Proc. Natl. Acad. Sci. USA 93, 12412-12417.
20. Hatakeyama, S., Jenson, J.P., and Weissman, A.M. (1997). Subcellular localization and ubiquitin-conjugating enzyme (E2) interactions of mammalian HECT family ubiquitin protein ligases. J. Biol. Chem. 272, 15085-15092.
21. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299.
22. Hegde, A.N., Inokuchi, K., Pei, W., Casadio, A., Ghirardi, M., Chain, D.G., Martin, K.C., Kandel, E.R., and Schwartz, J.H. (1997). Ubiquitin C-terminal hydrolase is an immediate-early gene essential for long-term facilitation in Aplysia. Cell 89, 115-126.
23. Hicke, L., and Riezman, H. (1996). Ubiquitination of a yeast plasma membrane receptor signals its ligand-stimulated endocytosis. Cell 84, 277-287.
24. Hochstrasser, M. (1996a). Protein degradation or regulation: Ub the judge. Cell 84, 813-815.
25. Hochstrasser, M. (1996b). Ubiquitin-dependent protein degradation. Annu. Rev. Genet. 30, 405-439.
26. Horsthemke, B., Dittrich, B., and Buiting, K. (1997). Imprinting mutations on human chromosome 15. Hum. Mutat. 10, 329-337.
27. Huibregtse, J.M., Scheffner, M., and Howley, P.M. (1991). A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10, 4129-4135.
28. Huibregtse, J.M., Scheffner, M., and Howley, P.M. (1993). Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell. Biol. 13, 775-784.
29. Huibregtse, J.M., Scheffner, M., Beaudenon, S., and Howley, P.M. (1995). A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Natl. Acad. Sci. USA 92, 2563-2567.
30. Jay, V., Becker, L.E., Chan, F.-W., and Perry, T.L., Sr. (1991). Puppet-like syndrome of Angelman: a pathologic and neurochemical study. Neurology 41, 416-422.
31. Jiang, Y., Tsai, T.-F., Bressler, J., and Beaudet, A.L. (1998). Imprinting in Angelman and Prader-Willi syndromes. Curr. Opin. Genet. Dev. 8, 334-342.
32. Kim, J.J., and Fanselow, M.S. (1992). Modality-specific retrograde amnesia of fear. Science 256, 675-677.
33. Kim, J.J., Rison, R.A., and Fanselow, M.S. (1993). Effects of amygdala, hippocampus, and periaqueductal gray lesions on short- and long-term contextual fear. Behav. Neurosci. 107, 1093-1098.
34. Kishino, T., Lalande, M., and Wagstaff, J. (1997). UBE3A/E6-AP mutations cause Angelman syndrome. Nat. Genet. 15, 70-73.
35. Klann, E., Chen, S.J., and Sweatt, J.D. (1991). Persistent protein kinase activation in the maintenance phase of long-term potentiation. J. Biol. Chem. 266, 24253-24256.
36. Klann, E., Chen, S.J., and Sweatt, J.D. (1993). Mechanism of protein kinase C activation during the induction and maintenance of long-term potentiation probed using a selective peptide substrate. Proc. Natl. Acad. Sci. USA 90, 8337-8341.
37. Ko, L.J., and Prives, C. (1998). p53: puzzle and paradigm. Genes Dev. 10, 1054-1072.
38. Kubbutat, M.H., Jones, S.N., and Vousden, K.H. (1997). Regulation of p53 stability by Mdm2. Nature 387, 299-303.
39. Kumar, S., Kao, W.H., and Howley, P.M. (1997). Physical interaction between specific E2 and Hect E3 enzymes determines functional cooperativity. J. Biol. Chem. 272, 13548-13554.
40. Lalande, M. (1996). Parental imprinting and human disease. Annu. Rev. Genet. 30, 173-195.
41. Masutani, C., Sugasawa, K., Yanagisawa, J., Sonoyama, T., Ui, M., Enomoto, T., Takio, K., Tanaka, K., van der Spek, P.J., Bootsma, D., et al. (1994). Purification and cloning of a nucleotide excision repair complex involving the xeroderma pigmentosum group C protein and a human homologue of yeast RAD23. EMBO J. 13, 1831-1843.
42. Matsuura, T., Sutcliffe, J.S., Fang, P., Galjaard, R.-J., Jiang, Y.-H., Benton, C.S., Rommens, J.M., and Beaudet, A.L. (1997). De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat. Genet. 15, 74-77.
43. McNish, K.A., Gewirtz, J.C., and Davis, M. (1997). Evidence of contextual fear after lesions of the hippocampus: a disruption of freezing but not fear-potentiated startle. J. Neurosci. 17, 9353-9360.
44. Minassian, B.A., Delorey, T.M., Olsen, R.W., Philippart, M., Bronstein, Y., Zhang, Q., Guerrini, R., Van, N.P., Livet, M.O., and Delgado-Escueta, A.V. (1998). Angelman syndrome: correlations between epilepsy phenotypes and genotypes. Ann. Neurol. 43, 485-493.
45. Nakao, M., Sutcliffe, J.S., Durtschi, B., Mutirangura, A., Ledbetter, D.H., and Beaudet, A.L. (1994). Imprinting analysis of three genes in the Prader-Willi/Angelman region: SNRPN, E6-associated protein, and PAR-2 (D15S225E). Hum. Mol. Genet. 3, 309-315.
46. Oh, C.E., McMahon, R., Benzer, S., and Tanouye, M.A. (1994). bendless, a Drosophila gene affecting neuronal connectivity, encodes a ubiquitin-conjugating enzyme homolog. J. Neurosci. 14, 3166-3179.
47. Perry, W.L., Hustad, C.M., Swing, D.A., O'Sullivan, T.N., Jenkins, N.A., and Copeland, N.G. (1998). The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice. Nat. Genet. 18, 143-146.
48. Phillips, R.G., and LeDoux, J.E. (1992). Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 106, 274-285.
49. Piette, J., Neel, H., and Marechal, V. (1997). Mdm2: keeping p53 under control. Oncogene 15, 1001-1010.
50. Pomerantz, J., Schreiber-Agus, N., Liegeois, N.J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.W., et al. (1998). The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92, 713-723.
51. Powell, C.M., Johnston, D., and Sweatt, J.D. (1994). Autonomously active protein kinase C in the maintenance phase of N-methyl-D-aspartate receptor-independent long term potentiation. J. Biol. Chem. 269, 27958-27963.
52. Robb, S.A., Pohl, K.R.E., Wilson, B.J., and Brett, E.M. (1989). The 'happy puppet' syndrome of Angelman: review of the clinical features. Arch. Dis. Child. 64, 83-86.
53. Roberson, E.D., and Sweatt, J.D. (1996). Transient activation of cyclic AMP-dependent protein kinase during hippocampal long-term potentiation. J. Biol. Chem. 271, 30436-30441.
54. Rougeulle, C., Glatt, H., and Lalande, M. (1997). The Angelman syndrome candidate gene, UBE3/A/E6-AP, is imprinted in brain. Nat. Genet. 17, 14-15.
55. Sacktor, T.C., Osten, P., Valsamis, H., Jiang, X., Naik, M.U., and Sublette, E. (1993). Persistent activation of the zeta isoform of protein kinase C in the maintenance of long-term potentiation. Proc. Natl. Acad. Sci. USA 90, 8342-8346.
56. Saitoh, S., Harada, H., Jinno, Y., Hashimoto, K., Imaizumi, K., Kuroki, Y., Fukushima, Y., Sugimoto, T., Renedo, M., Wagstaff, et al. (1994). Molecular and clinical study of 61 Angelman syndrome patients. Am. J. Med. Genet. 52, 158-163.
57. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning. A Laboratory Manual (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press).
58. Scheffner, M., Nuber, U., and Huibregtse, J.M. (1995). Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 373, 81-83.
59. Shaulsky, G., Ben-Ze'ev, A., and Rotter, V. (1990). Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene 5, 1707-1711.
60. Shaulsky, G., Goldfinger, N., Tosky, M.S., Levine, A.J., and Rotter, V. (1991). Nuclear localization is essential for the activity of p53 protein. Oncogene 6, 2055-2065.
61. Stevens, C.F. (1998). A million dollar question: Does LTP = memory? Neuron 20, 1-2.
62. Sutcliffe, J.S., Nakao, M., Christian, S., Orstavik, K.H., Tommerup, N., Ledbetter, D.H., and Beaudet, A.L. (1994). Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nat. Genet. 8, 52-58.
63. Sweatt, J.D., and Kandel, E.R. (1989). Persistent and transcriptionally-dependent increase in protein phosphorylation in long-term facilitation of Aplysia sensory neurons. Nature 339, 51-54.
64. Talis, A.L., Huibregtse, J.M., and Howley, P.M. (1998). The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J. Biol. Chem. 273, 6439-6445.
65. Vicari, E.M. (1951). Fatal convulsive seizures in the DBA mouse strain. J. Psychol. 32, 79-97.
66. Vu, T.H., and Hoffman, A.R. (1997). Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain. Nat. Genet. 17, 12-13.
67. Williams, C.A., Zori, R.T., Hendrickson, J., Stalker, H., Marum, T., Whidden, E., and Driscoll, D.J. (1995). Angelman syndrome. Curr. Probl. Pediatr. 25, 216-231.
68. Yamamoto, Y., Huibregtse, J.M., and Howley, P.M. (1997). The human E6-AP gene (UBE3A) encodes three potential protein isoforms generated by differential splicing. Genomics 41, 263-266.
69. Zhen, M., Schein, J.E., Baillie, D.L., and Candido, E.P. (1996). An essential ubiquitin-conjugating enzyme with tissue and developmental specificity in the nematode Caenorhabditis elegans. EMBO J. 15, 3229-3237.